1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Galbraith, T.P.
Harris, R.
Driscoll, P.C.
Wallace, B.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C4 H9 N O2
103.120
n
ALPHA-AMINOISOBUTYRIC ACID
L-peptide linking
C5 H11 N O2
117.146
D-ISOVALINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C5 H9 N O3
131.130
n
4-HYDROXYPROLINE
HYDROXYPROLINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C9 H13 N O
151.206
n
L-PHENYLALANINOL
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
US
Biophys. J.
BIOJAU
0030
0006-3495
84
185
194
10.1016/S0006-3495(03)74841-3
12524274
Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide.
2003
UK
Structure
STRUE6
2005
0969-2126
6
783
792
10.1016/S0969-2126(98)00079-3
9655831
The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide.
1998
NE
Biochim. Biophys. Acta
BBACAQ
0113
0006-3002
1415
255
260
10.1016/S0005-2736(98)00184-9
9858744
Antiamoebin can function as a carrier or as a pore-forming peptaibol.
1998
HYP A 13 C-ALPHA WRONG HAND IN ALL MODELS, PHL A 16 C-ALPHA WRONG HAND IN ALL MODELS
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1654.991
ANTIAMOEBIN I
1
nat
polymer
no
yes
(ACE)F(AIB)(AIB)(AIB)(DIV)GL(AIB)(AIB)(HYP)Q(DIV)(HYP)(AIB)P(PHL)
XFAAAVGLAAPQVPAPF
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
489044
EMERICELLOPSIS SP. 2723
citation
citation_author
repository
Initial release
Atomic model
Database references
Derived calculations
Structure summary
Version format compliance
Other
Database references
1
0
2003-01-24
1
1
2011-07-13
1
2
2012-11-30
1
3
2017-12-20
_citation.journal_abbrev
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_citation_author.name
CRYSTAL STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I
SOLUTION STRUCTURE OF THE PEPTAIBOL CHRYSOSPERMIN C BOUND TO DPC MICELLES
CRYSTAL STRUCTURE OF THE PEPTAIBOL ALAMETHICIN
CRYSTAL STRUCTURE OF THE PEPTAIBOL TRICHOTOXIN_A50E
CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL A
CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL B
CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL C
SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB IN METHANOL
SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB BOUND TO DPC MICELLES
SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB IN ISOTROPIC SOLVENTS
PDBE
Y
PDBE
2001-11-16
REL
ANTIAMOEBIN I IS LINEAR PEPTIDE, A MEMBER OF THE PEPTAIBOL
FAMILY OF MEMBRANE CHANNEL FORMING PEPTIDES.
HERE, ANTIAMOEBIN I IS REPRESENTED BY THE SEQUENCE (SEQRES)
GROUP: 1
NAME: ANTIAMOEBIN I
CHAIN: A
COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 0 TO 16
DESCRIPTION: ANTIAMOEBIN I IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0)
THE ANTIBIOTIC REPORTED HERE IS SIMILAR IN STRUCTURE TO THAT
FOUND IN EMBL:AAB11467 FROM THE SPECIES ACREMONIUM TUBAKII
Antibiotic
ANTIAMOEBIN I IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0)
Antiamoebin 1
Peptaibol
LOWEST ENERGY
100
20
NOESY
ROESY
DQF-COSY
TOCSY
HSQC
7.0
pH
1
atm
298
K
246 ATOMS USED IN SIMULATED ANNEALING (INCLUDING HYDROGENS) RMSD VALUES FROM IDEAL GEOMETRY FOR 20 MODELS: BOND DISTANCES 0.013 ANGSTROMS, STANDARD DEVIATION 0.0001 BOND ANGLES 2.92 DEGREES, STANDARD DEVIATION 0.017 IMPROPER ANGLES 6.62 DEGREES, STANDARD DEVIATION 0.028
simulated annealing
1
BRUNGER
refinement
X-PLOR
3.1
structure solution
MARDIGRAS
structure solution
XPLOR
500
Varian
UNITYPLUS
ACE
0
n
1
ACE
0
A
PHE
1
n
2
PHE
1
A
AIB
2
n
3
AIB
2
A
AIB
3
n
4
AIB
3
A
AIB
4
n
5
AIB
4
A
DIV
5
n
6
DIV
5
A
GLY
6
n
7
GLY
6
A
LEU
7
n
8
LEU
7
A
AIB
8
n
9
AIB
8
A
AIB
9
n
10
AIB
9
A
HYP
10
n
11
HYP
10
A
GLN
11
n
12
GLN
11
A
DIV
12
n
13
DIV
12
A
HYP
13
n
14
HYP
13
A
AIB
14
n
15
AIB
14
A
PRO
15
n
16
PRO
15
A
PHL
16
n
17
PHL
16
A
author_and_software_defined_assembly
PISA
1
monomeric
A
AIB
2
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
3
ALA
A
AIB
3
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
4
ALA
A
AIB
4
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
5
ALA
A
AIB
8
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
9
ALA
A
AIB
9
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
10
ALA
A
HYP
10
4-HYDROXYPROLINE
A
HYP
11
PRO
A
HYP
13
4-HYDROXYPROLINE
A
HYP
14
PRO
A
AIB
14
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
15
ALA
A
PHL
16
L-PHENYLALANINOL
A
PHL
17
PHE
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
CA
HYP
13
WRONG HAND
1
A
CA
PHL
16
WRONG HAND
2
A
CA
HYP
13
WRONG HAND
2
A
CA
PHL
16
WRONG HAND
3
A
CA
HYP
13
WRONG HAND
3
A
CA
PHL
16
WRONG HAND
4
A
CA
HYP
13
WRONG HAND
4
A
CA
PHL
16
WRONG HAND
5
A
CA
HYP
13
WRONG HAND
5
A
CA
PHL
16
WRONG HAND
6
A
CA
HYP
13
WRONG HAND
6
A
CA
PHL
16
WRONG HAND
7
A
CA
HYP
13
WRONG HAND
7
A
CA
PHL
16
WRONG HAND
8
A
CA
HYP
13
WRONG HAND
8
A
CA
PHL
16
WRONG HAND
9
A
CA
HYP
13
WRONG HAND
9
A
CA
PHL
16
WRONG HAND
10
A
CA
HYP
13
WRONG HAND
10
A
CA
PHL
16
WRONG HAND
11
A
CA
HYP
13
WRONG HAND
11
A
CA
PHL
16
WRONG HAND
12
A
CA
HYP
13
WRONG HAND
12
A
CA
PHL
16
WRONG HAND
13
A
CA
HYP
13
WRONG HAND
13
A
CA
PHL
16
WRONG HAND
14
A
CA
HYP
13
WRONG HAND
14
A
CA
PHL
16
WRONG HAND
15
A
CA
HYP
13
WRONG HAND
15
A
CA
PHL
16
WRONG HAND
16
A
CA
HYP
13
WRONG HAND
16
A
CA
PHL
16
WRONG HAND
17
A
CA
HYP
13
WRONG HAND
17
A
CA
PHL
16
WRONG HAND
18
A
CA
HYP
13
WRONG HAND
18
A
CA
PHL
16
WRONG HAND
19
A
CA
HYP
13
WRONG HAND
19
A
CA
PHL
16
WRONG HAND
20
A
CA
HYP
13
WRONG HAND
20
A
CA
PHL
16
WRONG HAND
2
A
A
O
H
HYP
PHL
13
16
1.52
3
A
A
O
H
HYP
PHL
13
16
1.53
4
A
A
O
H
HYP
PHL
13
16
1.57
5
A
A
O
H
GLY
AIB
6
9
1.58
6
A
A
O
H
HYP
PHL
13
16
1.51
6
A
A
O
H
GLY
AIB
6
9
1.59
7
A
A
O
H
HYP
PHL
13
16
1.52
8
A
A
O
H
HYP
PHL
13
16
1.51
8
A
A
O
H
GLY
AIB
6
9
1.52
9
A
A
O
H
HYP
PHL
13
16
1.50
9
A
A
O
H
GLY
AIB
6
9
1.56
13
A
A
O
H
HYP
PHL
13
16
1.50
13
A
A
O
H
GLY
AIB
6
9
1.57
14
A
A
O
H
GLY
AIB
6
9
1.52
15
A
A
O
H
HYP
PHL
13
16
1.53
16
A
A
O
H
GLY
AIB
6
9
1.50
16
A
A
O
H
HYP
PHL
13
16
1.50
18
A
A
O
H
HYP
PHL
13
16
1.53
18
A
A
O
H
GLY
AIB
6
9
1.56
19
A
A
O
H
GLY
AIB
6
9
1.51
20
A
A
O
H
AIB
DIV
8
12
1.49
20
A
A
O
H
HYP
PHL
13
16
1.52
1
A
AIB
2
-65.05
56.39
1
A
AIB
3
-176.90
-33.54
1
A
AIB
4
-8.73
73.91
1
A
DIV
5
27.51
65.98
1
A
LEU
7
22.77
45.84
1
A
AIB
8
159.42
-23.24
1
A
DIV
12
-38.84
-37.20
1
A
HYP
13
-4.54
-59.22
1
A
AIB
14
-35.94
-79.87
2
A
AIB
3
164.94
-23.25
2
A
AIB
4
-7.81
86.26
2
A
DIV
5
29.42
66.04
2
A
LEU
7
33.17
79.51
2
A
HYP
13
-2.61
-62.92
2
A
AIB
14
14.75
-79.86
2
A
PRO
15
-38.93
-34.85
3
A
AIB
2
-65.43
58.72
3
A
AIB
3
178.45
-27.29
3
A
AIB
4
-21.75
85.92
3
A
LEU
7
32.33
86.46
3
A
DIV
12
-35.99
-38.36
3
A
HYP
13
-4.21
-58.12
3
A
AIB
14
-0.68
-67.18
3
A
PRO
15
-38.73
-35.66
4
A
AIB
2
-64.32
64.85
4
A
AIB
3
143.46
-7.78
4
A
AIB
4
-24.77
84.69
4
A
DIV
5
29.61
60.07
4
A
LEU
7
35.81
65.41
4
A
HYP
10
-86.07
35.78
4
A
DIV
12
-38.59
-60.90
4
A
HYP
13
18.97
-66.14
4
A
AIB
14
-23.00
-58.74
4
A
PRO
15
-39.53
-35.83
5
A
AIB
2
-61.52
68.65
5
A
AIB
3
172.60
-26.50
5
A
AIB
4
-21.95
83.79
5
A
LEU
7
34.81
51.02
5
A
DIV
12
-31.40
-35.01
5
A
HYP
13
-0.51
-61.34
5
A
AIB
14
6.63
-72.47
5
A
PRO
15
-33.76
-33.91
6
A
AIB
2
-62.11
68.22
6
A
AIB
3
-175.20
-33.10
6
A
AIB
4
-24.40
89.72
6
A
DIV
5
35.55
70.21
6
A
LEU
7
36.49
58.31
6
A
AIB
8
40.83
29.92
6
A
DIV
12
-38.06
-44.68
6
A
HYP
13
4.73
-63.65
6
A
AIB
14
-7.85
-64.18
6
A
PRO
15
-39.18
-35.14
7
A
AIB
2
-65.66
59.20
7
A
AIB
3
-171.04
-33.75
7
A
AIB
4
-25.90
87.50
7
A
LEU
7
31.81
69.86
7
A
DIV
12
-37.91
-40.50
7
A
HYP
13
-0.47
-63.39
7
A
AIB
14
9.31
-76.25
7
A
PRO
15
-37.08
-31.55
8
A
AIB
2
-66.78
64.52
8
A
AIB
3
-171.59
-33.67
8
A
AIB
4
-24.71
87.30
8
A
LEU
7
39.25
34.37
8
A
AIB
8
75.80
-2.02
8
A
DIV
12
-39.43
-45.99
8
A
HYP
13
-1.28
-63.06
8
A
AIB
14
11.53
-79.93
8
A
PRO
15
-36.50
-30.18
9
A
AIB
2
-63.50
63.32
9
A
AIB
3
164.00
-23.90
9
A
AIB
4
-25.07
88.30
9
A
LEU
7
37.98
47.69
9
A
AIB
8
47.00
28.32
9
A
HYP
13
11.30
-64.18
9
A
AIB
14
-15.28
-58.09
10
A
AIB
2
-65.48
55.47
10
A
AIB
3
-169.17
-33.72
10
A
AIB
4
-26.10
92.94
10
A
LEU
7
35.56
68.75
10
A
AIB
8
46.37
22.87
10
A
DIV
12
-34.05
-39.45
10
A
HYP
13
-6.75
-57.21
10
A
AIB
14
-42.82
-78.79
10
A
PRO
15
-38.94
-30.81
11
A
AIB
2
-64.22
59.46
11
A
AIB
3
-178.64
-28.08
11
A
AIB
4
-23.02
88.07
11
A
HYP
10
-86.24
33.94
11
A
HYP
13
-3.47
-60.69
11
A
AIB
14
13.30
-77.75
11
A
PRO
15
-33.81
-31.77
12
A
AIB
2
-66.45
61.71
12
A
AIB
3
156.61
-22.02
12
A
AIB
4
-14.86
78.56
12
A
LEU
7
21.02
60.78
12
A
AIB
8
148.25
-35.92
12
A
AIB
9
-32.60
-35.87
12
A
HYP
13
2.64
-57.15
12
A
AIB
14
-18.33
-80.25
12
A
PRO
15
-30.99
-37.41
13
A
AIB
2
-66.25
56.53
13
A
AIB
3
-177.20
-30.50
13
A
AIB
4
-15.16
81.05
13
A
LEU
7
31.35
71.93
13
A
AIB
8
82.87
-18.82
13
A
AIB
9
-27.41
-38.44
13
A
HYP
10
-81.11
37.39
13
A
DIV
12
-38.10
-42.96
13
A
HYP
13
-5.39
-59.72
13
A
AIB
14
2.75
-80.41
13
A
PRO
15
-33.05
-32.70
14
A
AIB
2
-66.36
63.33
14
A
AIB
3
160.42
-25.46
14
A
AIB
4
-31.71
84.61
14
A
LEU
7
37.50
44.63
14
A
AIB
8
48.09
27.35
14
A
HYP
10
-84.84
30.62
14
A
HYP
13
-16.61
-50.50
14
A
AIB
14
17.34
-79.43
14
A
PRO
15
-37.33
-27.41
15
A
AIB
2
-63.01
65.17
15
A
AIB
3
-162.28
-34.59
15
A
AIB
4
-20.13
90.35
15
A
DIV
5
38.81
70.26
15
A
LEU
7
32.23
70.67
15
A
DIV
12
-38.39
-41.37
15
A
HYP
13
-2.88
-61.24
15
A
AIB
14
14.27
-80.33
15
A
PRO
15
-37.84
-33.71
16
A
AIB
2
-67.28
64.11
16
A
AIB
3
167.90
-24.23
16
A
AIB
4
-21.40
83.35
16
A
LEU
7
34.99
37.99
16
A
AIB
8
58.01
18.42
16
A
DIV
12
-29.57
-51.11
16
A
HYP
13
6.82
-68.75
16
A
AIB
14
4.19
-73.57
16
A
PRO
15
-37.49
-28.48
17
A
AIB
2
-61.01
68.84
17
A
AIB
3
-170.64
-28.80
17
A
AIB
4
-18.47
87.20
17
A
HYP
10
-81.25
31.73
17
A
HYP
13
-4.56
-56.85
17
A
AIB
14
-36.18
-77.87
17
A
PRO
15
-36.55
-30.63
18
A
AIB
2
-65.32
59.07
18
A
AIB
3
164.20
-24.22
18
A
AIB
4
-29.19
91.61
18
A
LEU
7
45.83
28.40
18
A
AIB
8
81.64
15.48
18
A
DIV
12
-32.60
-44.57
18
A
HYP
13
4.65
-63.61
18
A
AIB
14
-9.94
-67.38
19
A
AIB
2
-65.37
60.63
19
A
AIB
3
146.56
-17.46
19
A
AIB
4
-35.21
85.92
19
A
LEU
7
36.62
35.69
19
A
DIV
12
-34.87
-45.81
19
A
HYP
13
-8.69
-56.14
19
A
AIB
14
-38.53
-80.65
19
A
PRO
15
-37.25
-29.00
20
A
AIB
2
-62.81
63.96
20
A
AIB
3
-158.91
-36.35
20
A
AIB
4
-24.71
84.98
20
A
LEU
7
36.93
58.56
20
A
DIV
12
-37.25
-41.82
20
A
HYP
13
0.87
-61.57
20
A
AIB
14
-6.23
-69.00
20
A
PRO
15
-38.17
-36.64
ANTIAMOEBIN I
Solution structure of Antiamoebin I, a membrane channel-forming polypeptide; NMR, 20 structures
1
N
N
A
AIB
3
A
AIB
4
HELX_P
A
AIB
8
A
AIB
9
1
1
6
A
AIB
9
A
AIB
10
HELX_P
A
DIV
12
A
DIV
13
5
2
4
covale
1.347
A
ACE
0
A
C
ACE
1
1_555
A
PHE
1
A
N
PHE
2
1_555
covale
1.351
A
PHE
1
A
C
PHE
2
1_555
A
AIB
2
A
N
AIB
3
1_555
covale
1.368
A
AIB
2
A
C
AIB
3
1_555
A
AIB
3
A
N
AIB
4
1_555
covale
1.374
A
AIB
3
A
C
AIB
4
1_555
A
AIB
4
A
N
AIB
5
1_555
covale
1.372
A
AIB
4
A
C
AIB
5
1_555
A
DIV
5
A
N
DIV
6
1_555
covale
1.348
A
DIV
5
A
C
DIV
6
1_555
A
GLY
6
A
N
GLY
7
1_555
covale
1.350
A
LEU
7
A
C
LEU
8
1_555
A
AIB
8
A
N
AIB
9
1_555
covale
1.371
A
AIB
8
A
C
AIB
9
1_555
A
AIB
9
A
N
AIB
10
1_555
covale
1.367
A
AIB
9
A
C
AIB
10
1_555
A
HYP
10
A
N
HYP
11
1_555
covale
1.326
A
HYP
10
A
C
HYP
11
1_555
A
GLN
11
A
N
GLN
12
1_555
covale
1.353
A
GLN
11
A
C
GLN
12
1_555
A
DIV
12
A
N
DIV
13
1_555
covale
1.384
A
DIV
12
A
C
DIV
13
1_555
A
HYP
13
A
N
HYP
14
1_555
covale
1.365
A
HYP
13
A
C
HYP
14
1_555
A
AIB
14
A
N
AIB
15
1_555
covale
1.368
A
AIB
14
A
C
AIB
15
1_555
A
PRO
15
A
N
PRO
16
1_555
covale
1.330
A
PRO
15
A
C
PRO
16
1_555
A
PHL
16
A
N
PHL
17
1_555
ANTIBIOTIC
ANTIAMOEBIN I, PEPTAIBOL, ANTIBACTERIAL, ANTIFUNGAL, ANTIBIOTIC
NOR00945
NOR
1
NOR00945
0
16
1GQ0
0
16
NOR00945
A
1
1
17
1
P 1